Global Netherton Syndrome Supply, Demand and Key Producers, 2024-2030

Description

The global Netherton Syndrome market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Netherton syndrome is a rare disorder characterized by trichorrhexis invaginata, atopic diathesis, and ichthyosiform erythroderma. The trichorrhexis invaginata indicates short and brittle hair, atopic diathesis represents susceptibility to allergy problems while ichthyosiform erythroderma encompasses red, inflamed, scaly skin. Netherton syndrome is hereditary as it is an autosomal recessive trait.

This report studies the global Netherton Syndrome demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Netherton Syndrome, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Netherton Syndrome that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Netherton Syndrome total market, 2019-2030, (USD Million)
Global Netherton Syndrome total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Netherton Syndrome total market, key domestic companies and share, (USD Million)
Global Netherton Syndrome revenue by player and market share 2019-2024, (USD Million)
Global Netherton Syndrome total market by Type, CAGR, 2019-2030, (USD Million)
Global Netherton Syndrome total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Netherton Syndrome market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lifemax Laboratories, Inc., Azitra, Inc., Sixera Pharma Ab, Dermelix Biotherapeutics, Matrisys Bioscience, Quoin Pharmaceuticals Ltd. and Krystal Biotech, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Netherton Syndrome market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Netherton Syndrome Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Netherton Syndrome Market, Segmentation by Type
    Keratolytic Agents
    Oral and Topical Steroids and Retinoid
    Topical Calcineurin Inhibitors
    Radiation Therapies
    Biological Therapies
    Others

Global Netherton Syndrome Market, Segmentation by Application
    Hospital
    Clinic
    Others

Companies Profiled:
    Lifemax Laboratories, Inc.
    Azitra, Inc.
    Sixera Pharma Ab
    Dermelix Biotherapeutics
    Matrisys Bioscience
    Quoin Pharmaceuticals Ltd.
    Krystal Biotech, Inc.

Key Questions Answered
1. How big is the global Netherton Syndrome market?
2. What is the demand of the global Netherton Syndrome market?
3. What is the year over year growth of the global Netherton Syndrome market?
4. What is the total value of the global Netherton Syndrome market?
5. Who are the major players in the global Netherton Syndrome market?

Table of Contents

1 Supply Summary
    1.1 Netherton Syndrome Introduction
    1.2 World Netherton Syndrome Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Netherton Syndrome Total Market by Region (by Headquarter Location)
        1.3.1 World Netherton Syndrome Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Netherton Syndrome Market Size (2019-2030)
        1.3.3 China Netherton Syndrome Market Size (2019-2030)
        1.3.4 Europe Netherton Syndrome Market Size (2019-2030)
        1.3.5 Japan Netherton Syndrome Market Size (2019-2030)
        1.3.6 South Korea Netherton Syndrome Market Size (2019-2030)
        1.3.7 ASEAN Netherton Syndrome Market Size (2019-2030)
        1.3.8 India Netherton Syndrome Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Netherton Syndrome Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Netherton Syndrome Major Market Trends

2 Demand Summary
    2.1 World Netherton Syndrome Consumption Value (2019-2030)
    2.2 World Netherton Syndrome Consumption Value by Region
        2.2.1 World Netherton Syndrome Consumption Value by Region (2019-2024)
        2.2.2 World Netherton Syndrome Consumption Value Forecast by Region (2025-2030)
    2.3 United States Netherton Syndrome Consumption Value (2019-2030)
    2.4 China Netherton Syndrome Consumption Value (2019-2030)
    2.5 Europe Netherton Syndrome Consumption Value (2019-2030)
    2.6 Japan Netherton Syndrome Consumption Value (2019-2030)
    2.7 South Korea Netherton Syndrome Consumption Value (2019-2030)
    2.8 ASEAN Netherton Syndrome Consumption Value (2019-2030)
    2.9 India Netherton Syndrome Consumption Value (2019-2030)

3 World Netherton Syndrome Companies Competitive Analysis
    3.1 World Netherton Syndrome Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Netherton Syndrome Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Netherton Syndrome in 2023
        3.2.3 Global Concentration Ratios (CR8) for Netherton Syndrome in 2023
    3.3 Netherton Syndrome Company Evaluation Quadrant
    3.4 Netherton Syndrome Market: Overall Company Footprint Analysis
        3.4.1 Netherton Syndrome Market: Region Footprint
        3.4.2 Netherton Syndrome Market: Company Product Type Footprint
        3.4.3 Netherton Syndrome Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Netherton Syndrome Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Netherton Syndrome Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Netherton Syndrome Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Netherton Syndrome Consumption Value Comparison
        4.2.1 United States VS China: Netherton Syndrome Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Netherton Syndrome Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Netherton Syndrome Companies and Market Share, 2019-2024
        4.3.1 United States Based Netherton Syndrome Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Netherton Syndrome Revenue, (2019-2024)
    4.4 China Based Companies Netherton Syndrome Revenue and Market Share, 2019-2024
        4.4.1 China Based Netherton Syndrome Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Netherton Syndrome Revenue, (2019-2024)
    4.5 Rest of World Based Netherton Syndrome Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Netherton Syndrome Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Netherton Syndrome Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Netherton Syndrome Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Keratolytic Agents
        5.2.2 Oral and Topical Steroids and Retinoid
        5.2.3 Topical Calcineurin Inhibitors
        5.2.4 Radiation Therapies
        5.2.5 Biological Therapies
        5.2.6 Others
    5.3 Market Segment by Type
        5.3.1 World Netherton Syndrome Market Size by Type (2019-2024)
        5.3.2 World Netherton Syndrome Market Size by Type (2025-2030)
        5.3.3 World Netherton Syndrome Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Netherton Syndrome Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Netherton Syndrome Market Size by Application (2019-2024)
        6.3.2 World Netherton Syndrome Market Size by Application (2025-2030)
        6.3.3 World Netherton Syndrome Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Lifemax Laboratories, Inc.
        7.1.1 Lifemax Laboratories, Inc. Details
        7.1.2 Lifemax Laboratories, Inc. Major Business
        7.1.3 Lifemax Laboratories, Inc. Netherton Syndrome Product and Services
        7.1.4 Lifemax Laboratories, Inc. Netherton Syndrome Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Lifemax Laboratories, Inc. Recent Developments/Updates
        7.1.6 Lifemax Laboratories, Inc. Competitive Strengths & Weaknesses
    7.2 Azitra, Inc.
        7.2.1 Azitra, Inc. Details
        7.2.2 Azitra, Inc. Major Business
        7.2.3 Azitra, Inc. Netherton Syndrome Product and Services
        7.2.4 Azitra, Inc. Netherton Syndrome Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Azitra, Inc. Recent Developments/Updates
        7.2.6 Azitra, Inc. Competitive Strengths & Weaknesses
    7.3 Sixera Pharma Ab
        7.3.1 Sixera Pharma Ab Details
        7.3.2 Sixera Pharma Ab Major Business
        7.3.3 Sixera Pharma Ab Netherton Syndrome Product and Services
        7.3.4 Sixera Pharma Ab Netherton Syndrome Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Sixera Pharma Ab Recent Developments/Updates
        7.3.6 Sixera Pharma Ab Competitive Strengths & Weaknesses
    7.4 Dermelix Biotherapeutics
        7.4.1 Dermelix Biotherapeutics Details
        7.4.2 Dermelix Biotherapeutics Major Business
        7.4.3 Dermelix Biotherapeutics Netherton Syndrome Product and Services
        7.4.4 Dermelix Biotherapeutics Netherton Syndrome Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Dermelix Biotherapeutics Recent Developments/Updates
        7.4.6 Dermelix Biotherapeutics Competitive Strengths & Weaknesses
    7.5 Matrisys Bioscience
        7.5.1 Matrisys Bioscience Details
        7.5.2 Matrisys Bioscience Major Business
        7.5.3 Matrisys Bioscience Netherton Syndrome Product and Services
        7.5.4 Matrisys Bioscience Netherton Syndrome Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Matrisys Bioscience Recent Developments/Updates
        7.5.6 Matrisys Bioscience Competitive Strengths & Weaknesses
    7.6 Quoin Pharmaceuticals Ltd.
        7.6.1 Quoin Pharmaceuticals Ltd. Details
        7.6.2 Quoin Pharmaceuticals Ltd. Major Business
        7.6.3 Quoin Pharmaceuticals Ltd. Netherton Syndrome Product and Services
        7.6.4 Quoin Pharmaceuticals Ltd. Netherton Syndrome Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Quoin Pharmaceuticals Ltd. Recent Developments/Updates
        7.6.6 Quoin Pharmaceuticals Ltd. Competitive Strengths & Weaknesses
    7.7 Krystal Biotech, Inc.
        7.7.1 Krystal Biotech, Inc. Details
        7.7.2 Krystal Biotech, Inc. Major Business
        7.7.3 Krystal Biotech, Inc. Netherton Syndrome Product and Services
        7.7.4 Krystal Biotech, Inc. Netherton Syndrome Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Krystal Biotech, Inc. Recent Developments/Updates
        7.7.6 Krystal Biotech, Inc. Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Netherton Syndrome Industry Chain
    8.2 Netherton Syndrome Upstream Analysis
    8.3 Netherton Syndrome Midstream Analysis
    8.4 Netherton Syndrome Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Netherton Syndrome Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Netherton Syndrome Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Netherton Syndrome Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Netherton Syndrome Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Netherton Syndrome Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Netherton Syndrome Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Netherton Syndrome Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Netherton Syndrome Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Netherton Syndrome Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Netherton Syndrome Players in 2023
    Table 12. World Netherton Syndrome Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Netherton Syndrome Company Evaluation Quadrant
    Table 14. Head Office of Key Netherton Syndrome Player
    Table 15. Netherton Syndrome Market: Company Product Type Footprint
    Table 16. Netherton Syndrome Market: Company Product Application Footprint
    Table 17. Netherton Syndrome Mergers & Acquisitions Activity
    Table 18. United States VS China Netherton Syndrome Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Netherton Syndrome Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Netherton Syndrome Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Netherton Syndrome Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Netherton Syndrome Revenue Market Share (2019-2024)
    Table 23. China Based Netherton Syndrome Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Netherton Syndrome Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Netherton Syndrome Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Netherton Syndrome Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Netherton Syndrome Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Netherton Syndrome Revenue Market Share (2019-2024)
    Table 29. World Netherton Syndrome Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Netherton Syndrome Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Netherton Syndrome Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Netherton Syndrome Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Netherton Syndrome Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Netherton Syndrome Market Size by Application (2025-2030) & (USD Million)
    Table 35. Lifemax Laboratories, Inc. Basic Information, Area Served and Competitors
    Table 36. Lifemax Laboratories, Inc. Major Business
    Table 37. Lifemax Laboratories, Inc. Netherton Syndrome Product and Services
    Table 38. Lifemax Laboratories, Inc. Netherton Syndrome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Lifemax Laboratories, Inc. Recent Developments/Updates
    Table 40. Lifemax Laboratories, Inc. Competitive Strengths & Weaknesses
    Table 41. Azitra, Inc. Basic Information, Area Served and Competitors
    Table 42. Azitra, Inc. Major Business
    Table 43. Azitra, Inc. Netherton Syndrome Product and Services
    Table 44. Azitra, Inc. Netherton Syndrome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Azitra, Inc. Recent Developments/Updates
    Table 46. Azitra, Inc. Competitive Strengths & Weaknesses
    Table 47. Sixera Pharma Ab Basic Information, Area Served and Competitors
    Table 48. Sixera Pharma Ab Major Business
    Table 49. Sixera Pharma Ab Netherton Syndrome Product and Services
    Table 50. Sixera Pharma Ab Netherton Syndrome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Sixera Pharma Ab Recent Developments/Updates
    Table 52. Sixera Pharma Ab Competitive Strengths & Weaknesses
    Table 53. Dermelix Biotherapeutics Basic Information, Area Served and Competitors
    Table 54. Dermelix Biotherapeutics Major Business
    Table 55. Dermelix Biotherapeutics Netherton Syndrome Product and Services
    Table 56. Dermelix Biotherapeutics Netherton Syndrome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Dermelix Biotherapeutics Recent Developments/Updates
    Table 58. Dermelix Biotherapeutics Competitive Strengths & Weaknesses
    Table 59. Matrisys Bioscience Basic Information, Area Served and Competitors
    Table 60. Matrisys Bioscience Major Business
    Table 61. Matrisys Bioscience Netherton Syndrome Product and Services
    Table 62. Matrisys Bioscience Netherton Syndrome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Matrisys Bioscience Recent Developments/Updates
    Table 64. Matrisys Bioscience Competitive Strengths & Weaknesses
    Table 65. Quoin Pharmaceuticals Ltd. Basic Information, Area Served and Competitors
    Table 66. Quoin Pharmaceuticals Ltd. Major Business
    Table 67. Quoin Pharmaceuticals Ltd. Netherton Syndrome Product and Services
    Table 68. Quoin Pharmaceuticals Ltd. Netherton Syndrome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Quoin Pharmaceuticals Ltd. Recent Developments/Updates
    Table 70. Krystal Biotech, Inc. Basic Information, Area Served and Competitors
    Table 71. Krystal Biotech, Inc. Major Business
    Table 72. Krystal Biotech, Inc. Netherton Syndrome Product and Services
    Table 73. Krystal Biotech, Inc. Netherton Syndrome Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 74. Global Key Players of Netherton Syndrome Upstream (Raw Materials)
    Table 75. Netherton Syndrome Typical Customers
List of Figure
    Figure 1. Netherton Syndrome Picture
    Figure 2. World Netherton Syndrome Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Netherton Syndrome Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Netherton Syndrome Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Netherton Syndrome Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Netherton Syndrome Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Netherton Syndrome Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Netherton Syndrome Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Netherton Syndrome Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Netherton Syndrome Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Netherton Syndrome Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Netherton Syndrome Revenue (2019-2030) & (USD Million)
    Figure 13. Netherton Syndrome Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Netherton Syndrome Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Netherton Syndrome Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Netherton Syndrome Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Netherton Syndrome Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Netherton Syndrome Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Netherton Syndrome Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Netherton Syndrome Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Netherton Syndrome Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Netherton Syndrome Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Netherton Syndrome by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Netherton Syndrome Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Netherton Syndrome Markets in 2023
    Figure 27. United States VS China: Netherton Syndrome Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Netherton Syndrome Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Netherton Syndrome Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Netherton Syndrome Market Size Market Share by Type in 2023
    Figure 31. Keratolytic Agents
    Figure 32. Oral and Topical Steroids and Retinoid
    Figure 33. Topical Calcineurin Inhibitors
    Figure 34. Radiation Therapies
    Figure 35. Biological Therapies
    Figure 36. Others
    Figure 37. World Netherton Syndrome Market Size Market Share by Type (2019-2030)
    Figure 38. World Netherton Syndrome Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 39. World Netherton Syndrome Market Size Market Share by Application in 2023
    Figure 40. Hospital
    Figure 41. Clinic
    Figure 42. Others
    Figure 43. Netherton Syndrome Industrial Chain
    Figure 44. Methodology
    Figure 45. Research Process and Data Source

Companies Mentioned

Lifemax Laboratories, Inc.
Azitra, Inc.
Sixera Pharma Ab
Dermelix Biotherapeutics
Matrisys Bioscience
Quoin Pharmaceuticals Ltd.
Krystal Biotech, Inc.